STANDARD BIOTOOLS INC
LABNASDAQ🏆 #3111 by market capEarnings Nov 3US Equity
$0.78▼ $0.00 (−0.53%)
Live1h▲ 0.2%
24h▼ 0.5%
7d▲ 0.4%
14d▼ 10.3%
30d▼ 8.4%
1y▼ 40.7%
🏦Market Cap
$307M
Small Cap
📈Revenue Growth (YoY)
-45.1%
Declining
📊Gross Margin
50.5%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
3.7x
Fair
Otter Score
58
Weak
📊
Analyst Ratings
Price
$0.7833
Total
10
Raised
3
Lowered
3
Avg PT
$3.25
H / L
$3 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Reiterated | Hold | 2025-11-05 |
Keybanc | Downgraded | Overweight → Sector Weight | 2025-02-27 |
UBS | Reiterated | Buy | 2020-08-26 |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2019-11-05 |
Piper Sandler | Upgraded | Neutral → Overweight | 2018-11-01 |
Mizuho | Upgraded | Neutral → Buy | 2016-02-04 |
Deutsche Bank | Reiterated | Buy | 2016-02-04 |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2016-01-19 |
Cantor Fitzgerald | Upgraded | Hold → Buy | 2015-11-01 |
Leerink Swann | Reiterated | Outperform | 2015-05-07 |
One row per institution, most recent rating